Annual Cash & Cash Equivalents
$7.74 B
-$1.89 B-19.58%
December 1, 2024
Summary
- As of February 7, 2025, SNY annual cash & cash equivalents is $7.74 billion, with the most recent change of -$1.89 billion (-19.58%) on December 1, 2024.
- During the last 3 years, SNY annual cash & cash equivalents has fallen by -$3.69 billion (-32.28%).
- SNY annual cash & cash equivalents is now -43.31% below its all-time high of $13.66 billion, reached on December 31, 2022.
Performance
SNY Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$7.74 B
NaN%
December 1, 2024
Summary
- As of February 7, 2025, SNY quarterly cash and cash equivalents is $7.74 billion
- SNY quarterly cash and cash equivalents is now -56.89% below its all-time high of $17.96 billion, reached on June 30, 2020.
Performance
SNY Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SNY Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.6% | - |
| 3 y3 years | -32.3% | - |
| 5 y5 years | -26.7% | - |
SNY Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.3% | at low | -43.3% | +7.4% |
| 5 y | 5-year | -43.3% | at low | -56.9% | +7.4% |
| alltime | all time | -43.3% | +6976.2% | -56.9% | +6136.1% |
Sanofi Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $7.74 B(-19.6%) | $7.74 B(+6.3%) |
| Jun 2024 | - | $7.28 B(-24.4%) |
| Dec 2023 | $9.63 B(-29.5%) | $9.63 B(+10.8%) |
| Jun 2023 | - | $8.69 B(-36.4%) |
| Dec 2022 | $13.66 B(+19.5%) | $13.66 B(+89.5%) |
| Jun 2022 | - | $7.21 B(-37.0%) |
| Dec 2021 | $11.43 B(-7.9%) | $11.43 B(-1.2%) |
| Jun 2021 | - | $11.57 B(-35.6%) |
| Dec 2020 | $12.42 B(+17.6%) | - |
| Jun 2020 | - | $17.96 B(+70.1%) |
| Dec 2019 | $10.56 B(+33.3%) | $10.56 B(+37.8%) |
| Jun 2019 | - | $7.67 B(-3.2%) |
| Dec 2018 | $7.92 B(-36.0%) | $7.92 B(-8.6%) |
| Jun 2018 | - | $8.66 B(-30.0%) |
| Dec 2017 | $12.37 B(+13.9%) | $12.37 B(+13.9%) |
| Dec 2016 | $10.86 B(+8.6%) | $10.86 B(+8.6%) |
| Dec 2015 | $10.00 B(+12.0%) | $10.00 B(+89.7%) |
| Jun 2015 | - | $5.27 B(-40.9%) |
| Dec 2014 | $8.93 B(-21.7%) | $8.93 B(+52.0%) |
| Jun 2014 | - | $5.87 B(-48.5%) |
| Dec 2013 | $11.40 B(+35.1%) | $11.40 B(+109.2%) |
| Jun 2013 | - | $5.45 B(-35.4%) |
| Dec 2012 | $8.44 B | $8.44 B(+57.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $5.36 B(+0.3%) |
| Dec 2011 | $5.34 B(-37.9%) | $5.34 B(-43.6%) |
| Jun 2011 | - | $9.47 B(+10.1%) |
| Dec 2010 | $8.60 B(+28.1%) | $8.60 B(+118.3%) |
| Jun 2010 | - | $3.94 B(-41.3%) |
| Dec 2009 | $6.71 B(+13.6%) | $6.71 B(-23.1%) |
| Jun 2009 | - | $8.72 B(+47.7%) |
| Dec 2008 | $5.91 B(+136.5%) | $5.91 B(+296.1%) |
| Jun 2008 | - | $1.49 B(-40.3%) |
| Dec 2007 | $2.50 B(+64.1%) | $2.50 B(+70.4%) |
| Jun 2007 | - | $1.47 B(-3.7%) |
| Dec 2006 | $1.52 B(+3.0%) | $1.52 B(+2.5%) |
| Jun 2006 | - | $1.48 B(+0.5%) |
| Dec 2005 | $1.48 B(-40.7%) | $1.48 B(-45.9%) |
| Jun 2005 | - | $2.73 B(+9.5%) |
| Dec 2004 | $2.49 B(+1206.2%) | $2.49 B(+1431.8%) |
| Jun 2004 | - | $162.77 M(-14.7%) |
| Dec 2003 | $190.88 M(+26.5%) | $190.88 M(+53.7%) |
| Jun 2003 | - | $124.16 M(-17.7%) |
| Dec 2002 | $150.95 M(+38.0%) | $150.95 M(-20.9%) |
| Jun 2002 | - | $190.88 M |
| Dec 2001 | $109.42 M(-43.7%) | - |
| Dec 2000 | $194.41 M(-4.2%) | - |
| Dec 1999 | $203.03 M | - |
FAQ
- What is Sanofi annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sanofi?
- What is Sanofi annual cash & cash equivalents year-on-year change?
- What is Sanofi quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Sanofi?
What is Sanofi annual cash & cash equivalents?
The current annual cash & cash equivalents of SNY is $7.74 B
What is the all time high annual cash & cash equivalents for Sanofi?
Sanofi all-time high annual cash & cash equivalents is $13.66 B
What is Sanofi annual cash & cash equivalents year-on-year change?
Over the past year, SNY annual cash & cash equivalents has changed by -$1.89 B (-19.58%)
What is Sanofi quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SNY is $7.74 B
What is the all time high quarterly cash and cash equivalents for Sanofi?
Sanofi all-time high quarterly cash and cash equivalents is $17.96 B